Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration (EBUS-TBNA): A Practical Approach

Each paper needs an abstract limited to 200 words structured as follows: Objective, Study design, Results and Conclusions. For Novel Insights from Clinical Practice the headings should be: Background, Case and Conclusion. Address the study’s power to detect a diff erence if the research identifi ed important variables that lacked a statistically signifi cant diff erence. Footnotes: Footnotes should be avoided. When essential, they are numbered consecutively and typed at the foot of the appropriate page. Materials and Methods: Acknowledge that the original research was approved by the local institutional review board. Clearly state the method of any randomization, blinding and selection of specifi c statistical tests. Explain dropouts/exclusions and confounding variables. Tables and illustrations: Tables and illustrations (both numbered in Arabic numerals) should be prepared on separate pages. Tables require a heading and fi gures a legend, also prepared on a separate page. Due to technical reasons, fi gures with a screen background should not be submitted. When possible, group several illustrations in one block for reproduction (max. size 180 223 mm) or provide crop marks. Each illustration must be labelled with its number and the fi rst author’s name. Electronically submitted b/w half-tone and color illustrations must have a fi nal resolution of 300 dpi aft er scaling (fi nal size), line art drawings one of 800–1,200 dpi. Do not modify a low-resolution image by increasing the dpi. Figure fi les should not be embedded in a document fi le but submitted separately. All illustrations must include the original magnifi cation and the stain employed, and clearly identify critical areas of radiographs, photomicrographs, etc. Provide suffi cient information for a table to stand alone. Avoid tables in which the data could be included in the text in a few sentences. References: In the text identify references by Arabic numerals [in square brackets]. Material submitted for publication but not yet accepted should be noted as [unpublished data] and not be included in the reference list. Th e list of references should include only those publications which are cited in the text. In general, avoid listing unpublished data or manuscripts, personal communications, web sites and non-peer-reviewed publications. Do not alphabetize; number references in the order in which they are fi rst mentioned in the text. Th e surnames of the authors followed by initials should be given. Th ere should be no punctuation other than a comma to separate the authors. Preferably, please cite all authors. Abbreviate journal names according to the Index Medicus system. Also see International Committee of Medical Journal Editors: Uniform requirements for manuscripts submitted to biomedical journals (www.icmje.org). Authors using EndNote® may choose the format setting for Intervirology for the correct format of references. Examples (a) Papers published in periodicals: Vilhelmsson M, Johansson C, Jacobsson-Ekman G, Crameri R, Zargari A, Scheynius A: Th e malassezia sympodialis allergen Mala s 11 induces human dendritic cell maturation, in contrast to its human homologue manganese superoxide dismutase. Int Arch Allergy Immunol 2007;143:155–162. (b) Papers published only with DOI numbers: Th eoharides TC, Boucher W, Spear K: Serum interleukin-6 refl ects disease severity and osteoporosis in mastocytosis patients. Int Arch Allergy Immunol DOI: 10.1159/000063858. (c) Monographs: Matthews DE, Farewell VT: Using and Understanding Medical Statistics, ed 4, revised. Basel, Karger, 2007. (d) Edited books: Park BK, Sanderson JP, Naisbitt DJ: Drugs as haptens, antigens, and immunogens; in Pichler WJ (ed): Drug Hypersensitivity. Basel, Karger, 2007, pp 55–65. Color Illustrations For all manuscripts accepted, authors will be charged CHF 500.00 for each color page published in the print version of the journal. Several color illustration may be placed onto one color page. When the illustration appears in black and white in the printed version, the authors will not be charged a fee. In the online version all fi gures submitted in color will appear in color at no charge to the author. Referring to colors in the text and fi gure legends should be avoided. We recommend using symbols, instead of color, for charts and graphs. Ethics Published research must comply with the guidelines for human studies and animal welfare regulations. Authors should state that subjects have given their informed consent and that the study protocol has been approved by the institute’s committee on human research and thus meets the standards of the Declaration of Helsinki in its revised version of 1975 and its amendments of 1983, 1989, and 1996 [JAMA 1997;277:925–926]. Information suitable to reveal the subject’s identity is to be avoided. Further, authors should also state that animal experiments conform E-Mail karger@karger.com www.karger.com © 2014 S. Karger AG, Basel Th e Guidelines for Authors are available at: www.karger.com/acy_Guidelines D ow nl oa de d by : 54 . 7 0. 40 . 1 1 11 /2 5/ 20 17 9 :0 8: 09 P M to institutional standards. Copies of these guidelines and policy statements must be available for review by the editors if necessary. Confl ict of Interest All forms of funding and support, including that from companies, as well as any potential competing fi nancial interests should be acknowledged in the cover letter to the editors when applicable. Th e statement has to be listed at the end of the article. Digital Object Identifi er (DOI) S. Karger Publishers supports DOIs as unique identifi ers for articles. A DOI number will be printed on the title page of each article. DOIs can be useful in the future for identifying and citing articles published online without volume or issue information. More information can be found at www.doi. org. Supplementary Material Supplementary material is restricted to additional data that are not necessary for the scientifi c integrity and conclusions of the paper. Please note that all supplementary fi les will undergo editorial review and should be submitted together with the original manuscript. Th e Editors reserve the right to limit the scope and length of the supplementary material. Supplementary material must meet production quality standards for Web publication without the need for any modifi cation or editing. In general, supplementary fi les should not exceed 10 Mb in size. All fi gures and tables should have titles and legends and all fi les should be supplied separately and named clearly. Acceptable fi les and formats are: Word or PDF fi les, Excel spreadsheets (only if the data cannot be converted properly to a PDF fi le), and video fi les (.mov, .avi, .mpeg). Author’s ChoiceTM Karger’s Author’s ChoiceTM service broadens the reach of your article and gives all users worldwide free and full access for reading, downloading and printing at www. karger.com. Th e option is available for a onetime fee of CHF 3,000.00, which is a permissible cost in a grant allocation. More information can be found at www.karger. com/authors_choice. NIH-Funded Research Th e U.S. National Institutes of Health (NIH) mandates under the NIH Public Access Policy that fi nal, peer-reviewed manuscripts appear in its digital database within 12 months of the offi cial publication date. As a service to authors, Karger submits the fi nal version of your article on your behalf to PubMed Central. For those selecting our premium Author’s ChoiceTM service, we will send your article immediately upon publishing, accelerating the accessibility of your work without the usual embargo. More details on NIH’s Public Access Policy is available at http://publicaccess.nih. gov/FAQ.htm#a1. Self-Archiving Karger permits authors to archive their pre-prints (i.e. pre-refereeing) or post-prints (i.e. fi nal draft post-refereeing) on their personal or institution’s servers, provided the following conditions are met: Articles may not be used for commercial purposes, must be linked to the publisher’s version, and must acknowledge the publisher’s copyright. Authors selecting Karger’s Author’s ChoiceTM feature, however, are also permitted to archive the fi nal, published version of their article, which includes copyediting and design improvements as well as citation links. Copy Editing All manuscripts accepted for publication by Karger are subject to copy editing. Changes introduced by the copy editor and/or questions will be marked in the manuscript so please be sure to check the proofs against the manuscript. Th e copy edited manuscript will be returned along with the proofs. Proofs Unless indicated otherwise, proofs are sent to the corresponding author and should be returned with the least possible delay. Alterations made in proofs, other than the correction of printer’s errors, are charged to the author. No page proofs are supplied. Reprints An order form and a price list are sent with the proofs. Orders submitted aft er the release of an article in print are subject to considerably higher prices. Guidelines for Authors Online version for institutional purchase Prices subject to change. EUR price for Germany, USD price for USA and Latin America only Monographs in